Boston, MA, United States of America

Priscilla Yang

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 21(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Priscilla Yang: Innovator in Antiviral Compounds

Introduction

Priscilla Yang is a prominent inventor based in Boston, MA (US). She has made significant contributions to the field of antiviral research, holding 2 patents that focus on innovative compounds for treating viral infections. Her work is particularly relevant in the context of emerging viral threats.

Latest Patents

Priscilla Yang's latest patents include groundbreaking research on substituted heterocyclic compounds for treating or preventing viral infections. One of her notable inventions involves pyrimidine compounds designed to combat infections caused by the dengue virus. The methods disclosed in her patent detail the administration of these compounds to effectively treat or prevent viral infections. Another significant patent focuses on host-targeted inhibitors of dengue virus and other viruses. This patent presents novel antiviral compounds that are useful for the prevention and treatment of infectious diseases caused by various viruses, including Flaviviridae viruses and others.

Career Highlights

Throughout her career, Priscilla has worked with esteemed institutions such as Dana-Farber Cancer Institute and Harvard College. Her research has contributed to the understanding and development of antiviral therapies, showcasing her commitment to advancing medical science.

Collaborations

Priscilla has collaborated with notable colleagues, including Nathanael Schiander Gray and Qingsong Liu. These partnerships have further enriched her research and innovation in the field of virology.

Conclusion

Priscilla Yang stands out as a dedicated inventor whose work in antiviral compounds is making a significant impact in the fight against viral infections. Her contributions are vital in the ongoing battle against emerging infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…